Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine
Autor(a) principal: | |
---|---|
Data de Publicação: | 2000 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Archives of Biology and Technology |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132000000300002 |
Resumo: | Studies ere carried out to monitor the titres of anti-rabies antibodies taken from individuals exposed to the risk of infection. Fifty-seven individuals aged between 20 and 40, were vaccinated with a minimum titre of 1.3 IU Fuenzalida-Palacios type anti-rabies vaccine. The vaccination plan consisted of the application of three doses at two day intervals and a booster applied 28 days after the final dose. The accompainment of the antibody titres was achieved by means of the seroneutralization test over a total period of 18 months. Through the monitoring carried out, it was found to be necessary to apply a booster vaccination to part of the group. Some of these individuals were revaccinated with Fuenzalida-Palacios type vaccine with a minimum titre of 1.3 IU. And some with cellular vaccine with a minimum titre of 2.5 IU. All the individuals responded with titres greater than 0.5 IU, maintaining these levels until the end of the observation period, demonstrating a ready anamnestic response to both immunogens. |
id |
TECPAR-1_4a0981de8f81a33248aac4c6d16fd0ad |
---|---|
oai_identifier_str |
oai:scielo:S1516-89132000000300002 |
network_acronym_str |
TECPAR-1 |
network_name_str |
Brazilian Archives of Biology and Technology |
repository_id_str |
|
spelling |
Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccineImmunizationrabies vaccineantibodiesneutralizationFuenzalida-PalaciosStudies ere carried out to monitor the titres of anti-rabies antibodies taken from individuals exposed to the risk of infection. Fifty-seven individuals aged between 20 and 40, were vaccinated with a minimum titre of 1.3 IU Fuenzalida-Palacios type anti-rabies vaccine. The vaccination plan consisted of the application of three doses at two day intervals and a booster applied 28 days after the final dose. The accompainment of the antibody titres was achieved by means of the seroneutralization test over a total period of 18 months. Through the monitoring carried out, it was found to be necessary to apply a booster vaccination to part of the group. Some of these individuals were revaccinated with Fuenzalida-Palacios type vaccine with a minimum titre of 1.3 IU. And some with cellular vaccine with a minimum titre of 2.5 IU. All the individuals responded with titres greater than 0.5 IU, maintaining these levels until the end of the observation period, demonstrating a ready anamnestic response to both immunogens.Instituto de Tecnologia do Paraná - Tecpar2000-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132000000300002Brazilian Archives of Biology and Technology v.43 n.3 2000reponame:Brazilian Archives of Biology and Technologyinstname:Instituto de Tecnologia do Paraná (Tecpar)instacron:TECPAR10.1590/S1516-89132000000300002info:eu-repo/semantics/openAccessPreto,Angela AparecidaGomes,Elisa MainesFernandes,Maurício JoséHennig,Nei AdolfoGermano,Pedro Manoel Lealeng2007-03-12T00:00:00Zoai:scielo:S1516-89132000000300002Revistahttps://www.scielo.br/j/babt/https://old.scielo.br/oai/scielo-oai.phpbabt@tecpar.br||babt@tecpar.br1678-43241516-8913opendoar:2007-03-12T00:00Brazilian Archives of Biology and Technology - Instituto de Tecnologia do Paraná (Tecpar)false |
dc.title.none.fl_str_mv |
Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine |
title |
Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine |
spellingShingle |
Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine Preto,Angela Aparecida Immunization rabies vaccine antibodies neutralization Fuenzalida-Palacios |
title_short |
Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine |
title_full |
Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine |
title_fullStr |
Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine |
title_full_unstemmed |
Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine |
title_sort |
Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine |
author |
Preto,Angela Aparecida |
author_facet |
Preto,Angela Aparecida Gomes,Elisa Maines Fernandes,Maurício José Hennig,Nei Adolfo Germano,Pedro Manoel Leal |
author_role |
author |
author2 |
Gomes,Elisa Maines Fernandes,Maurício José Hennig,Nei Adolfo Germano,Pedro Manoel Leal |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Preto,Angela Aparecida Gomes,Elisa Maines Fernandes,Maurício José Hennig,Nei Adolfo Germano,Pedro Manoel Leal |
dc.subject.por.fl_str_mv |
Immunization rabies vaccine antibodies neutralization Fuenzalida-Palacios |
topic |
Immunization rabies vaccine antibodies neutralization Fuenzalida-Palacios |
description |
Studies ere carried out to monitor the titres of anti-rabies antibodies taken from individuals exposed to the risk of infection. Fifty-seven individuals aged between 20 and 40, were vaccinated with a minimum titre of 1.3 IU Fuenzalida-Palacios type anti-rabies vaccine. The vaccination plan consisted of the application of three doses at two day intervals and a booster applied 28 days after the final dose. The accompainment of the antibody titres was achieved by means of the seroneutralization test over a total period of 18 months. Through the monitoring carried out, it was found to be necessary to apply a booster vaccination to part of the group. Some of these individuals were revaccinated with Fuenzalida-Palacios type vaccine with a minimum titre of 1.3 IU. And some with cellular vaccine with a minimum titre of 2.5 IU. All the individuals responded with titres greater than 0.5 IU, maintaining these levels until the end of the observation period, demonstrating a ready anamnestic response to both immunogens. |
publishDate |
2000 |
dc.date.none.fl_str_mv |
2000-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132000000300002 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132000000300002 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S1516-89132000000300002 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Instituto de Tecnologia do Paraná - Tecpar |
publisher.none.fl_str_mv |
Instituto de Tecnologia do Paraná - Tecpar |
dc.source.none.fl_str_mv |
Brazilian Archives of Biology and Technology v.43 n.3 2000 reponame:Brazilian Archives of Biology and Technology instname:Instituto de Tecnologia do Paraná (Tecpar) instacron:TECPAR |
instname_str |
Instituto de Tecnologia do Paraná (Tecpar) |
instacron_str |
TECPAR |
institution |
TECPAR |
reponame_str |
Brazilian Archives of Biology and Technology |
collection |
Brazilian Archives of Biology and Technology |
repository.name.fl_str_mv |
Brazilian Archives of Biology and Technology - Instituto de Tecnologia do Paraná (Tecpar) |
repository.mail.fl_str_mv |
babt@tecpar.br||babt@tecpar.br |
_version_ |
1750318268291219456 |